ID25469A - Komposisi sefalosporin amorf yang stabil secara kristalografi dan proses pembuatannya - Google Patents
Komposisi sefalosporin amorf yang stabil secara kristalografi dan proses pembuatannyaInfo
- Publication number
- ID25469A ID25469A IDW20001303A ID20001303A ID25469A ID 25469 A ID25469 A ID 25469A ID W20001303 A IDW20001303 A ID W20001303A ID 20001303 A ID20001303 A ID 20001303A ID 25469 A ID25469 A ID 25469A
- Authority
- ID
- Indonesia
- Prior art keywords
- sefalosporine
- christalography
- amorf
- stories
- making
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
- A61K31/546—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine containing further heterocyclic rings, e.g. cephalothin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/14—Compounds having a nitrogen atom directly attached in position 7
- C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
- C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
- C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Inorganic Chemistry (AREA)
- Cephalosporin Compounds (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP192098 | 1998-01-07 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ID25469A true ID25469A (id) | 2000-10-05 |
Family
ID=11515039
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IDW20001303A ID25469A (id) | 1998-01-07 | 1999-01-07 | Komposisi sefalosporin amorf yang stabil secara kristalografi dan proses pembuatannya |
Country Status (22)
| Country | Link |
|---|---|
| US (2) | US6342493B1 (cs) |
| EP (1) | EP1051978B1 (cs) |
| JP (1) | JP3413406B2 (cs) |
| KR (1) | KR100435315B1 (cs) |
| CN (1) | CN1151845C (cs) |
| AU (1) | AU736555B2 (cs) |
| BR (1) | BRPI9907084B8 (cs) |
| CA (1) | CA2316841C (cs) |
| CZ (1) | CZ302082B6 (cs) |
| EA (1) | EA002881B1 (cs) |
| ES (1) | ES2393972T3 (cs) |
| HU (1) | HU230295B1 (cs) |
| ID (1) | ID25469A (cs) |
| IL (2) | IL137004A0 (cs) |
| NZ (1) | NZ505871A (cs) |
| PL (1) | PL194097B1 (cs) |
| PT (1) | PT1051978E (cs) |
| SK (1) | SK286631B6 (cs) |
| TR (1) | TR200001903T2 (cs) |
| TW (1) | TW587946B (cs) |
| UA (1) | UA70311C2 (cs) |
| WO (1) | WO1999034832A1 (cs) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HU230295B1 (hu) * | 1998-01-07 | 2015-12-28 | Meiji Seika Pharma Co., Ltd. | Kristálytanilag stabil, amorf, cephalosporin tartalmú készítmény és eljárás előállítására |
| ATE285821T1 (de) | 1999-10-08 | 2005-01-15 | Affinium Pharm Inc | Fab i inhibitoren |
| ES2320984T3 (es) | 2001-04-06 | 2009-06-01 | Affinium Pharmaceuticals, Inc. | Inhibidores de fab i. |
| EP1389462B1 (en) * | 2001-04-26 | 2012-06-06 | Meiji Seika Pharma Co., Ltd. | Amorphous cefditoren pivoxil composition and process for producing the same |
| ATE482710T1 (de) | 2002-10-02 | 2010-10-15 | Meiji Seika Kaisha | Antibakterielle medizinische zusammensetzung mit erhöhtem oralem absorptionsvermögen |
| AU2003298937A1 (en) | 2002-12-06 | 2004-06-30 | Affinium Pharmaceuticals, Inc. | Heterocyclic compounds, methods of making them and their use in therapy |
| JP4880448B2 (ja) * | 2003-03-17 | 2012-02-22 | アフィナム ファーマシューティカルズ，インコーポレーテッド | 複数の抗生物質を含む組成物、及びそれを用いる方法 |
| US20070167402A1 (en) * | 2003-06-20 | 2007-07-19 | Meiji Seika Kaisha, Ltd. | Product of coprecipitation of sparingly soluble substance and water-soluble polymer and process for producing the same |
| CN1863535A (zh) | 2003-10-08 | 2006-11-15 | 明治制果株式会社 | 含有头孢托仑匹伏酯的非晶性抗菌组合物 |
| EP1689755A2 (en) * | 2003-11-07 | 2006-08-16 | Ranbaxy Laboratories Limited | Processes for the preparation of highly pure 3-(2-substituted vinyl) cephalosporin |
| JP2005162696A (ja) * | 2003-12-04 | 2005-06-23 | Nichiko Pharmaceutical Co Ltd | 溶出性に優れたセフジトレンピボキシル製剤 |
| WO2005082330A2 (en) * | 2004-02-19 | 2005-09-09 | Ranbaxy Laboratories Limited | Co-precipitated amorphous cefditoren pivoxil and dosage forms comprising the same |
| KR101299399B1 (ko) | 2004-06-04 | 2013-08-22 | 아피늄 파마슈티컬스, 인크. | 치료제, 및 그의 제조 및 사용 방법 |
| US20080069879A1 (en) * | 2006-05-02 | 2008-03-20 | Ravishekhar Bhiwgade | Stable solid dosage form containing amorphous cefditoren pivoxil and process for preparation thereof |
| US8318720B2 (en) | 2006-07-20 | 2012-11-27 | Affinium Pharmaceuticals, Inc. | Acrylamide derivatives as Fab I inhibitors |
| WO2008057058A1 (en) * | 2006-11-10 | 2008-05-15 | Nobel Ilac Sanayii Ve Ticaret As | Oral pharmaceutical compositions |
| EP2125802A4 (en) | 2007-02-16 | 2014-08-20 | Debiopharm Int Sa | SALTS, PRODRUGS AND POLYMORPHES OF FAB I INHIBITORS |
| CN101560216B (zh) * | 2009-05-27 | 2011-06-15 | 上海交通大学 | 头孢妥仑酯的制备方法 |
| WO2012010938A2 (en) * | 2010-07-23 | 2012-01-26 | Lupin Limited | Pharmaceutical compositions of cefditoren pivoxil |
| SI2623497T1 (sl) | 2010-09-30 | 2016-04-29 | Toyama Chemical Co., Ltd. | Megluminska sol 6-fluoro-3-hidroksi-2-pirazinkarboksamida |
| US20130274472A1 (en) | 2010-09-30 | 2013-10-17 | Toyama Chemical Co., Ltd. | Sodium salt of 6-fluoro-3-hydroxy-2-pyrazine carboxamide |
| ME03392B (me) | 2012-06-19 | 2020-01-20 | Debiopharm Int Sa | Prolek derivati (e)-n-meтil-n-( (з-метi lbenzofuran-2-il)meтil)-3-(7 -okso-5 ,6, 7,8-тетrанidr0-1,8-nafтiridin-3-il)akrilamida |
| WO2015029066A1 (en) * | 2013-08-29 | 2015-03-05 | Cadila Healthcare Limited | Polymorphic form of pyrrole derivative and intermediate thereof |
| EP3244879A1 (en) | 2015-01-16 | 2017-11-22 | Ögün, Yusuf Toktamis | Cefditoren pivoxil compositions with improved stability and production methods thereof |
| ES2842443T3 (es) | 2016-02-26 | 2021-07-14 | Debiopharm Int Sa | Medicamento para el tratamiento de infecciones del pie diabético |
| CN109053768A (zh) * | 2018-08-07 | 2018-12-21 | 中国医药集团总公司四川抗菌素工业研究所 | 一种无定型头孢妥仑酯的制备方法 |
| MA54009B1 (fr) | 2019-02-14 | 2022-10-31 | Debiopharm Int Sa | Formulation d'afabicine et son procédé de préparation |
| CN110251467A (zh) * | 2019-06-26 | 2019-09-20 | 北京济美堂医药研究有限公司 | 一种无定形态头孢妥仑匹酯组合物的制备方法 |
| CN112190539B (zh) * | 2020-11-10 | 2021-11-02 | 深圳立健药业有限公司 | 一种头孢妥仑匹酯组合物及其应用 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0678234B2 (ja) * | 1988-04-19 | 1994-10-05 | 明治製菓株式会社 | 経口投与用抗菌組成物 |
| JPH05306227A (ja) * | 1992-04-27 | 1993-11-19 | Lion Corp | 徐放性口腔内疾患治療剤 |
| JP2576927B2 (ja) * | 1992-05-15 | 1997-01-29 | ファイザー製薬株式会社 | 細粒核 |
| JPH06316517A (ja) * | 1993-02-22 | 1994-11-15 | Grelan Pharmaceut Co Ltd | 放出制御製剤 |
| JPH0717866A (ja) * | 1993-06-16 | 1995-01-20 | Meiji Seika Kaisha Ltd | 医薬組成物 |
| AU4314196A (en) | 1994-12-21 | 1996-07-10 | Yamanouchi Pharmaceutical Co., Ltd. | Solid composition with improved solubility and absorbability |
| AR004014A1 (es) * | 1995-10-13 | 1998-09-30 | Meiji Seika Kaisha | Una composicion antibacteriana de cefditoren pivoxilo para administracion oral y metodo para obtener dicha composicion |
| PT904060E (pt) | 1996-05-20 | 2004-04-30 | Janssen Pharmaceutica Nv | Composicoes antifungicas com biodisponibilidades melhorada |
| UA55426C2 (uk) | 1996-09-20 | 2003-04-15 | Мейджі Сейка Кайша Лтд. | Кристалічний цефдиторен півоксилу і способи його одержання |
| HU230295B1 (hu) * | 1998-01-07 | 2015-12-28 | Meiji Seika Pharma Co., Ltd. | Kristálytanilag stabil, amorf, cephalosporin tartalmú készítmény és eljárás előállítására |
-
1999
- 1999-01-07 HU HU0101272A patent/HU230295B1/hu unknown
- 1999-01-07 TR TR2000/01903T patent/TR200001903T2/xx unknown
- 1999-01-07 ID IDW20001303A patent/ID25469A/id unknown
- 1999-01-07 CZ CZ20002542A patent/CZ302082B6/cs not_active IP Right Cessation
- 1999-01-07 CA CA002316841A patent/CA2316841C/en not_active Expired - Lifetime
- 1999-01-07 PL PL99341589A patent/PL194097B1/pl unknown
- 1999-01-07 SK SK1026-2000A patent/SK286631B6/sk not_active IP Right Cessation
- 1999-01-07 PT PT99900136T patent/PT1051978E/pt unknown
- 1999-01-07 JP JP2000527279A patent/JP3413406B2/ja not_active Expired - Lifetime
- 1999-01-07 WO PCT/JP1999/000020 patent/WO1999034832A1/ja active IP Right Grant
- 1999-01-07 AU AU17845/99A patent/AU736555B2/en not_active Ceased
- 1999-01-07 EP EP99900136A patent/EP1051978B1/en not_active Expired - Lifetime
- 1999-01-07 KR KR10-2000-7007546A patent/KR100435315B1/ko not_active Expired - Lifetime
- 1999-01-07 US US09/582,937 patent/US6342493B1/en not_active Expired - Lifetime
- 1999-01-07 CN CNB998027855A patent/CN1151845C/zh not_active Expired - Lifetime
- 1999-01-07 EA EA200000742A patent/EA002881B1/ru not_active IP Right Cessation
- 1999-01-07 ES ES99900136T patent/ES2393972T3/es not_active Expired - Lifetime
- 1999-01-07 IL IL13700499A patent/IL137004A0/xx unknown
- 1999-01-07 BR BRPI9907084A patent/BRPI9907084B8/pt not_active IP Right Cessation
- 1999-01-07 NZ NZ505871A patent/NZ505871A/xx not_active IP Right Cessation
- 1999-06-28 TW TW088110903A patent/TW587946B/zh not_active IP Right Cessation
- 1999-07-01 UA UA2000084638A patent/UA70311C2/uk unknown
-
2000
- 2000-06-26 IL IL137004A patent/IL137004A/en not_active IP Right Cessation
-
2001
- 2001-11-26 US US09/991,694 patent/US6486149B2/en not_active Expired - Lifetime
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ID25469A (id) | Komposisi sefalosporin amorf yang stabil secara kristalografi dan proses pembuatannya | |
| ID19290A (id) | Turunan-turunan propiofenon dan proses pembuatannya | |
| ID15947A (id) | Senyawa fenol dan proses pembuatannya | |
| ID27408A (id) | Benda penyerap dan proses pembuatannya | |
| ID17307A (id) | Komposisi oral dan proses pembuatannya. | |
| ID18047A (id) | Proses pembuatan bahan antara untuk florfenikol | |
| ID23557A (id) | Poliester baru dan proses pembuatan poliester | |
| ID28846A (id) | 2-fenilbenzimidazol dan 2_fenilindol, pembuatan dan penggunaanya | |
| ID26172A (id) | Proses pembuatan surfaktan-surfaktan alkilbenzenasulfonat dan produk-produknya | |
| ID19385A (id) | Adesif termosetting dan metoda pembuatannya | |
| ID25608A (id) | Struktur selulosa dengan kerapatan yang berbeda dan proses pembuatannya | |
| ID30299A (id) | Turunan oksazolidinon, proses pembuatannya dan komposisi farmasi yang mengandungnya | |
| ID16862A (id) | Komposisi-komposisi elastomer dan metoda-metoda pembuatannya | |
| ID23985A (id) | Baterai dan metode pembuatannya | |
| ID28728A (id) | Komposisi dan proses pengkrepan | |
| ID30506A (id) | Proses pengembangan ko-produksi 6-aminokapronitril dan heksametilenadiamino | |
| ID27814A (id) | Pengolahan-awal kostik bekas dan proses oksidasi yang diperkaya | |
| ID30238A (id) | Komposisi-komposisi amifostin amorf yang stabil dan metode-metode untuk pembuatan dan penggunaannya | |
| ID18661A (id) | Rakitan penyaringan menara proses kimia | |
| ID23963A (id) | Proses pembuatan vinil asetat | |
| ID24070A (id) | Katalis yang mengandung hologen dan proses pembuatannya | |
| ID22911A (id) | Turunan-turunan triazol baru, proses pembuatan dan komposisi-komposisi farmasi yang mengandungnya | |
| ID22641A (id) | Proses pembuatan e-kaprolaktam | |
| ID15992A (id) | Papan lamina dan proses pembuatannya | |
| ID20137A (id) | Turunan propanolamina, proses pembuatannya, sediaan farmasi yang mengandung senyawa ini, dan penggunannya |